← Back to home

ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY

Clinical trials for ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Simple blood tests may help predict ovarian cancer treatment success

Knowledge-focused Ongoing

This study investigates whether certain blood-based markers, such as the neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), and the CA-125 elimination rate (KELIM score), can predict survival and surgical outcomes in women with advanced ovarian cancer. Researcher…

Matched conditions: ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY

Sponsor: Aya Ahmed Nasser • Aim: Knowledge-focused

Last updated Jul 02, 2026 07:00 UTC

ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY

Get alerted when new ADVANCED OVARIAN CANCER (STAGE III OR IV) AFTER NEOADJUVANT CHEMOTHERAPY trials appear

Simple blood tests may help predict ovarian cancer treatment success